Pfizer Inc

NYSE: PFE
$28.45
-$0.19 (-0.7%)
Closing Price on October 25, 2024

PFE Articles

Despite the howling from political candidates trying to make the top drug-makers their whipping boy in populist campaign efforts, the need and demand for pharmaceuticals will only continue. This...
November 23, 2015: Markets opened mixed on Monday with very slight positive or negative differences from Friday’s closing prices. The trading band for all three major indexes was quite narrow today...
A new Jefferies research report highlights four top companies that could be looking at catalysts that in the very near term could have a huge impact on the stocks.
Jefferies has updated the thesis behind its "Top 5 for 2015" pharmaceutical stock picks
The short interest data have been released for the October 30 settlement date, and for most of the selected pharmaceutical stocks, short interest was down.
November 4, 2015: Markets opened higher on Wednesday following an in-line report on jobs from ADP and somewhat smaller-than-expected U.S. trade deficit. The EIA report on crude oil stockpiles showed...
Solid growth stocks that pay good dividends make sense, especially when they all pay higher dividends than the current 30-year U.S. Treasury bond.
The health care sector may have sold off a fair amount since this past summer, but there is some M&A action between giants in the sector that has potential to heat it back up.
November 2, 2015: Markets opened higher on Monday and added strength as the day drew to a close. Healthcare and energy stocks carried the weight today even though WTI crude oil for December delivery...
Last week, a few biotech companies made absolutely massive runs, and some had serious falls.
October 30, 2015: Markets opened higher on Friday before falling into the red until the early afternoon. Financial stocks could not get untracked, but energy stocks were able to pick up the slack. It...
ThinkstockOctober 29, 2015: Markets opened lower on Thursday after a GDP report that was a bit softer than expected and a somewhat better-than-expected report on new jobless claims. Quarterly results...
Allergan has issued a press release that confirms some of the rumors floating in the market that it has been approached by Pfizer.
Pfizer and Merck both released their third-quarter earnings on Tuesday morning. So, which drug giant is looking better after earnings?
The October 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest was mixed.